Опубликовать статью

Информационное партнерство

Инфоресурсы

Контакты

«

Vol. 17, Art. 2 (pp. 12-23)    |    2016       

»

Clinical and epidemiological profile of a teenage cancer: part 2

S.V. Ivanova1, A.P. Karitskiy1, S.A. Kuleva1,2, N.D. Faseeva1

1Federal State Budget Institution "Research Institute of Oncology. NN Petrov"
2State budget educational institution of higher professional education "Saint Petersburg State Pediatric Medical University"

Brief summary

Adolescents and young adults with cancer are a special group among cancer patients. Many problems faced by patients of this age from symptoms manifestation, during intensive treatment and subsequent rehabilitation, overlooked or underestimated by most specialists. There are several reasons that affect a worse prognosis in young people, some of which we will try to describe in the article.


Key words

adolescents, young adults, risk factors, tumor biology, treatment regimens, long-term effects.

Reference list

1. Butow?P.,?Palmer?S.,?Pai?A.?et al. Review of adherence-related issues in adolescents and young adults with cancer?// J. Clin. Oncol. - 2010. - Vol.?28. - P. 4800-4809.


2. Pieters R.S., Wagner H., Baker S. et al. The impact of protocol assignment for older adolescents with Hodgkin lymphoma //?Front. Oncol. - 2014. - Vol. 4. - R.1-9.


3. Veal G.J., Hartford C.M., Stewart C.F. et al. Clinical pharmacology in the adolescent oncology patients //?J. Clin. Oncol. - 2010. - Vol. 28. - R. 4790-4799.


4. Wu X., Groves F. Cancer incidence patterns among adolescents and young adults in the United States?// Cancer Causes and Control. -?2005. - Vol. 16. - R. 309-320.


5. Pentheroudakis G., Pavlis N. Juvenile cancer: Improving care for adolescents and young adults within the frame of medical oncology?// Ann. Oncol.?- 2005. - Vol. 16. - R. 181-188.


6. McGlynn K.A., Cook M.B. Etiologic factors in testicular germ cell tumors?// Future Oncol. - 2009. - Vol. 5. - R. 1389-1402.


7. Dieckmann K.P.,?Pichlmeier U. Clinical epidemiology of testicular germ cell tumors // World J. Urol.?- 2004. - Vol. 22(1). - R. 2-14.


8. N.E. Skakkebæk,?E. Rajpert-De Meyts,?K.M. Main. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. // Hum. Reprod.?- 2001. - Vol.?16?(5). - R.972-978.?


9. Bleyer A., O'Leary M., Barr R., Ries L. Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975-2000 // National Cancer Institute, NIH Pub. No. 06-5767. Bethesda, MD. - 2006. - 218 p.


10. Bleyer A., Budd T., Montello M. et al. Adolescents and young adults with cancer // Cancer. - 2006. - Vol. 107. - R. 1645-1655.


11. Anders C.K., Johnson R., Litton J. et al. Breast cancer before age 40 years?// Semin. Oncol. - 2009. - Vol. 36(3). - R. 237-249.


12. Kheirelseid E.A., Boggs J.M., Curran C. Younger age as a prognostic indicator in breast cancer: A cohort study?// BMC Cancer. - 2011. - Vol. 11. - R. 383 - 394.


13. Tebbi C.K.,?Cummings K.M.,?Zevon M.A. et al. Compliance of pediatric and adolescent cancer patients // Cancer. - 1986. - Vol. 58(5). - R. 1179-1184.


14. Smith E. C., Ziogas A., Anton-Culver H. et al. Association between insurance and socioeconomic status and risk of advanced stage Hodgkin lymphoma in adolescents and young adults // Cancer. - 2012. - Vol. 118. - R. 6179-6187.


15. Ferrari A. Participation of adolescents with cancer in clinical trials // Cancer Treat. Rev. - 2013. - Vol. 33. - R. 603 - 608.


16. Kulyova S.A., Kolygin B.A. Hodgkin?s lymphoma in children and adolescents: a Saint Petersburg Hodgkin?s Lymphoma Group Study // J. Oncol. - 2011. - V. 2011: 958435.


17. Koligin B.A., Kyleva S.A. Diagnostika i lechenie limfomi Hodjkina // Spb, ?Gippokrat?, 2009. - 208 s.


18. Herbertson R., Hancock B.W. Hodgkin lymphoma in adolescents // Cancer Treat. Rev. - 2005. - Vol. 31. - R. 339-360.


19. Donaldson S.S., Hudson M.M., Lamborn K.R. VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin disease: results of a prospective clinical trial // J. Clin. Oncol. - 2002. - Vol. 20. - R. 3081-3087.


20. Schellong G., Potter R., Bramswig J. et al. High cure rates and reduced long-term toxicity in pediatric Hodgkin disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin Disease Study Group // J. Clin. Oncol. - 1999. - Vol. 17. - R. 3736-3744.


21. Landman-Parker J., Pacquement H., Leblanc T. et al. Localized childhood Hodgkin disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy - results of the French Society of Pediatric Oncology Study MDH90 // J. Clin. Oncol. - 2000. - Vol. 18. - R. 1500-1507.


22. Yung L., Smith P., Hancock B.W. et al. Long-term outcome in adolescents with Hodgkin lymphoma: poor results using regimens designed for adults // Leuk. Lymphoma. - 2004. - Vol. 45. - P. 1579-1585.


23. Wolfson J.,?Sun C.L.,?Kang T. et al. Impact of treatment site in adolescents and young adults with central nervous system tumors // J. Natl. Cancer Inst.?- 2014. - Vol. 106(8). - R. 166.


24. Lange B.J., Gerbing R.B., Feusner J. et al. Mortality in overweight and underweight children with acute myeloid leukemia //?JAMA.?- 2005. - Vol. 293. - R. 203-211.


25. Meinhardt U.J., Ho K.K.Y. Modulation of growth hormone action by sex steroids // Clin. Endocrinol. - 2006. - Vol. 65. - R. 413-422.


26. Rifkind A.B., Saenger P., Levine L.S. et al. Effects of growth hormone on antipyrine kinetics in children // Clin. Pharmacol. Therapeutics. - 1981. - Vol. 30. - R. 127-132.


27. Ng A.K., Bernardo M.V.P., Weller E. et al. Second malignancy after Hodgkin Disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors // Blood. - 2002. - Vol. 100. - R.1989-1996.


28. Bhatia S., Yasui Y., Robison L.L. et al. High risk of subsequent neoplasms continues with extended follow up of childhood Hodgkin disease: report from the Late Effects Study Group // J. Clin. Oncol. - 2003. - Vol. 21. - R. 4386-4394.


29. Hancock S.L., Donaldson S.S., Hoppe R.T. et al. Cardiac disease following treatment of Hodgkin disease in children and adolescents // J. Clin. Oncol. - 1993. - Vol. 11. - R. 1208-1215.


30. Koligin B.A., Kyleva S.A. Posledstviya protivoopyholevoi terapii y detei // Spb, ?Gippokrat?, 2011. - 184 s.


31. Laskar S., Gupta T., Vimal S. et al. Consolidation radiation after complete remission in Hodgkin disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: is there a need? // J. Clin. Oncol. - 2004. - Vol. 22. - R. 62-68.


32. Ng A.K., Bernardo M.V.P., Weller E. et al. Second malignancy after Hodgkin Disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors // Blood. - 2002. - Vol. 100. - R. 1989-1996.